cp wire

CP Wire Articles

Next-Gen Cancer Immunotherapy Company Banks $75 Million Oversubscribed Series B Round

iTeos Therapeutics SA announced on 6/20/2018 the completion of an oversubscribed $75 million (€64 million) Series B financing led by MPM Capital, with participation from additional new investors... read more

Wed, 06/20/18 - 09:34 am
Genedrive plc Receives Grant to Develop Test to Avoid Antibiotic-related Hearing Loss in Newborns

Genedrive plc announced on 6/20/2018 its receipt of a multi-partner grant award from the UK National Institute for Health Research’s Invention for Innovation programme, for the development and... read more

Wed, 06/20/18 - 09:18 am
OncBioMune Announces Good News for Ph II Trial of Prostate Cancer Vaccine
  • ProscaVax is OncBioMune’s lead immunotherapy platform candidate
  • Ph I trials led to PSA reductions in 3/4 of patients

OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("... read more

Wed, 06/20/18 - 09:06 am
FDA Awards Regenerative Medicine Advanced Therapy Designation to Caladrius' Refractory Angina Treatment

Caladrius Biosciences, Inc. (Nasdaq:CLBS) announced on 6/19/2018 that the U.S. Food and Drug Administration (“FDA”) has granted regenerative medicine... read more

Tue, 06/19/18 - 09:38 am
CrownBio and Pierre Fabre Partner to Advance Development of Immuno-Oncology Therapies

Crown Bioscience announced on 6/19/2018 that it has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline.

... read more

Tue, 06/19/18 - 09:19 am

Pages